On Friday, Tango Therapeutics Inc (NASDAQ: TNGX) was -5.72% drop from the session before settling in for the closing price of $6.29. A 52-week range for TNGX has been $6.12 – $13.01.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 132.62% over the last five years. When this article was written, the company’s average yearly earnings per share was at -22.90%. With a float of $58.48 million, this company’s outstanding shares have now reached $102.20 million.
The firm has a total of 140 workers. Let’s measure their productivity. In terms of profitability, gross margin is 94.15%, operating margin of -311.57%, and the pretax margin is -273.63%.
Tango Therapeutics Inc (TNGX) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tango Therapeutics Inc stocks. The insider ownership of Tango Therapeutics Inc is 46.14%, while institutional ownership is 56.76%. The most recent insider transaction that took place on Oct 25 ’24, was worth 629,000. Before that another transaction happened on Oct 21 ’24, when Company’s sold 625,000 for $7.05, making the entire transaction worth $4,406,250. This insider now owns 7,573,642 shares in total.
Tango Therapeutics Inc (TNGX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -22.90% per share during the next fiscal year.
Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators
You can see what Tango Therapeutics Inc (TNGX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.49. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.13, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.46 in one year’s time.
Technical Analysis of Tango Therapeutics Inc (TNGX)
Analysing the last 5-days average volume posted by the [Tango Therapeutics Inc, TNGX], we can find that recorded value of 1.18 million was better than the volume posted last year of 0.77 million. As of the previous 9 days, the stock’s Stochastic %D was 9.97%. Additionally, its Average True Range was 0.57.
During the past 100 days, Tango Therapeutics Inc’s (TNGX) raw stochastic average was set at 1.62%, which indicates a significant decrease from 6.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.82% in the past 14 days, which was lower than the 76.87% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.67, while its 200-day Moving Average is $9.07. Now, the first resistance to watch is $6.66. This is followed by the second major resistance level at $7.40. The third major resistance level sits at $7.81. If the price goes on to break the first support level at $5.51, it is likely to go to the next support level at $5.10. Now, if the price goes above the second support level, the third support stands at $4.36.
Tango Therapeutics Inc (NASDAQ: TNGX) Key Stats
There are 106,846K outstanding shares of the company, which has a market capitalization of 635.34 million. As of now, sales total 36,530 K while income totals -101,740 K. Its latest quarter income was 19,880 K while its last quarter net income were -25,550 K.
